Literature DB >> 1345333

High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study.

G Walldius1, I Jungner, W Kolar, I Holme, E Steiner.   

Abstract

In over 300,000 Swedish males and females aged 20 to 79 years total cholesterol and triglycerides were measured consecutively between 1985 and 1989. In a subsample of about 35,000 individuals apolipoprotein (apo) B (indicating atherogenic) and apo A-I (anti-atherogenic) were also measured. In the age group 40-49 years, 24% of the males and 12% of the females had hypercholesterolemia (> or = 6.5 mmol/L) and 14% and 3%, respectively had hypertriglyceridemia (> or = 2.3 mmol/L). Combined hyperlipidemia occurred in this age group in 7% of the males and in 1% of the females and was more common in males. In the same age group, 21% of the males and 8% of the females had high atherogenic apo B values (> 1.5 g/L). Low apo A-I was found in the whole population (20-79 years) in 13% of the males and in 10% of the females and varied only little with age. In the AMORIS (Apolipoprotein related MOrtality RISk) study these individuals are followed prospectively. The relations between lipids and apo B and apo A-I levels and risk for fatal acute myocardial infarction (AMI) are analyzed to investigate which of these lipids/apolipoproteins best predict AMI either as single determinants or in combination. After a mean observation time of about 22 months there is a 3-6-fold increase in AMI in relation to increasing cholesterol levels in males of 40-59 years. The largest increase was seen in the 40-49-year age group. A similar relationship was also found for triglycerides and AMI.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1345333

Source DB:  PubMed          Journal:  Blood Press Suppl        ISSN: 0803-8023


  19 in total

Review 1.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

2.  Hard drinking water and ischemic heart disease: calcium, bloodlipids, and acute myocardial infarcts.

Authors:  P Hall; I Jungner
Journal:  J Med Syst       Date:  1993-08       Impact factor: 4.460

3.  Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study.

Authors:  Mieke Van Hemelrijck; Danielle Harari; Hans Garmo; Niklas Hammar; Goran Walldius; Mats Lambe; Ingmar Jungner; Lars Holmberg
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-28

4.  Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study.

Authors:  Mieke Van Hemelrijck; Lars Holmberg; Hans Garmo; Niklas Hammar; Göran Walldius; Elisa Binda; Mats Lambe; Ingmar Jungner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-04       Impact factor: 4.254

5.  Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.

Authors:  Håkan Malmström; Göran Walldius; Valdemar Grill; Ingmar Jungner; Soffia Gudbjörnsdottir; Niklas Hammar
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

6.  Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study.

Authors:  Andrew Yiu; Mieke Van Hemelrijck; Hans Garmo; Lars Holmberg; Håkan Malmström; Mats Lambe; Niklas Hammar; Göran Walldius; Ingmar Jungner; Wahyu Wulaningsih
Journal:  Oncotarget       Date:  2017-06-27

7.  Iron metabolism and risk of cancer in the Swedish AMORIS study.

Authors:  Anjali Gaur; Helen Collins; Wahyu Wulaningsih; Lars Holmberg; Hans Garmo; Niklas Hammar; Göran Walldius; Ingmar Jungner; Mieke Van Hemelrijck
Journal:  Cancer Causes Control       Date:  2013-05-07       Impact factor: 2.506

8.  Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study.

Authors:  Wahyu Wulaningsih; Hans Garmo; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2012-08-30

9.  Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study.

Authors:  Wahyu Wulaningsih; Karl Michaelsson; Hans Garmo; Niklas Hammar; Ingmar Jungner; Göran Walldius; Mats Lambe; Lars Holmberg; Mieke Van Hemelrijck
Journal:  BMC Public Health       Date:  2013-07-17       Impact factor: 3.295

10.  Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality.

Authors:  Brittany M Bernardo; Robert C Orellana; Yiska Lowenberg Weisband; Niklas Hammar; Goran Walldius; Hakan Malmstrom; Anders Ahlbom; Maria Feychting; Judith Schwartzbaum
Journal:  Br J Cancer       Date:  2016-06-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.